Tradestie Institutional Equity Comparison Engine
LMRI vs MPLT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LMRI Overall Edge
LMRI Captures Institutional Edge (2โ1 Pillars ยท 1โ7 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LMRI (LMRI) driven by superior Momentum & Technical, Options & Structure while MPLT counters with relative strength in Growth & Margin. Fundamentally, LMRI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MPLT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LMRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
LMRI N/M vs MPLT N/M Fwd P/E
Growth & Margin Winner
MPLT
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
LMRI
1Y -23.0% vs -59.3% ยท 52W Pos 60% vs 0%
Options & Structure Winner
LMRI
UNCLASSIFIED (N/A IV) vs BREAKDOWN (9th %ile IV)
LMRI
US Equity
LMRI
Institutional Equity
$14.26
+1.42% 1D
Market Cap
N/A
1M Return
+30.95%
1Y Return
-23.0%
Forward P/E
N/M
Unified AI Score
32.1 / 100
SELL
Tech 50.0
Fund 30.0
Flow 50.0
Mom 50.0
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap
$356.8M
1M Return
-28.0%
1Y Return
-59.32%
Forward P/E
N/M
Unified AI Score
48.3 / 100
HOLD
Tech 33.0
Fund 64.0
Flow 67.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LMRI -23.0%
MPLT -59.32%
Spread: +47.44 pp (LMRI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
LMRI TTM Op. Margin: N/A
MPLT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LMRI vs MPLT. Trailing 12-month operating profitability (LMRI N/A vs MPLT 0.0%) and valuation multiples (LMRI N/M vs MPLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LMRI | MPLT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $356.8M | Larger Scale | MPLT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | MPLT |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | MPLT |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | MPLT |
| Return on Equity (ROE) Capital Efficiency | N/A | -74.2% | Higher ROE | MPLT |
| 52-Week Range Position Momentum | 60% ($6โ$19) | 0% ($6โ$40) | Stronger Trend | LMRI |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 85% Vol | 1.19ฮฒ ยท 79% Vol | Lower Realized Risk | MPLT |
| Unified Institutional Score Composite Signal | 32.1 / 100 (SELL) | 48.3 / 100 (HOLD) | Higher Composite | MPLT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LMRI vs MPLT Buy Guide
LMRI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MPLT
BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LMRI nor MPLT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.